This rapid compilation of data analyses provides a ‘stock-take’ of social science and behavioural data related to the on-going outbreak of Ebola in North Kivu, South Kivu and Ituri provinces. Based on data gathered and analysed by organisations working in the Ebola response and in the region mor...e broadly, it explores convergences and divergences between datasets and, when possible, differences by geographic area, demographic group, time period and other relevant variables. Data sources are listed at the end of the document.
more
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin...ating Group on Antimicrobial Resistance who released the report – drug-resistant diseases could cause 10 million deaths each year by 2050 and damage to the economy as catastrophic as the 2008-2009 global financial crisis. By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.
more
Regional action plan 2019-2023
AIDSTAR-One | CASE STUDY SERIES November 2012
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
12-13 December 2016
Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
ثیوبری هی 19 ّبی يفًَی ًهیز وٍَیذ تَاًٌذ هختل وٌٌذُ هحیف ّبیی ثبضٌذ وِ وَدوبى در آًْب رضذ هی وٌٌذ. اختلال ّبیی وِ در ایي ضزایف در خبًَادُ، رٍاثف دٍستبًِ، فًبلیت ّبی رٍ...سهزُ ٍ در سكحی ٍسیى تز در اجتوبو ایجبد هی هی، ضَد تَاًذ پیبهذّبی هٌفی ثز ثْشیستی، رضذ، تَسًِ ٍ حوبیت اس وَدوبى اًجبم هی 19 داضتِ ثبضذ. يلاٍُ ثز آى الذاهبتی وِ ثِ هٌهَر پیطگیزی ٍ وٌتزل ضیَو ٍیزٍس وٍَیذ ضَد ًیش هی تَاًذ هخبقزاتی را در سهیٌِ حوبیت اس وَدوبى ثِ ّوزاُ داضتِ ثبضذ .ثِ يٌَاى ًوًَِ لزًكیٌِ خبًگی، لزًكیٌِ هجتٌی ثز هزاوش یب ًَاحی یب ایشٍلِ ضذى در یه هحیف هحذٍد اس جولِ هَاردی ّستٌذ وِ هی ذ تبحیزات هٌفی ثز وَدوبى ٍ خبًَادُ ٌ تَاً 2 ّبیطبى ثگذارد. ّذف اس هختػزی وِ در اداهِ هی آیذ پطتیجبًی اس وسبًی است وِ در سهیٌِ حوبیت اس وَدوبى فًبلیت هی وٌٌذ تب ثتَاًٌذ پبسخگَیی ثْتزی ًسجت ثِ هخبقزات حوبیت اس وَدوبى در سهبى ّوِ گیزی ٍیزٍس وزًٍب داضتِ ثبضٌذ. در ثخص اٍل ثِ خكزات ثبلمَُ ی حوبیت اس وَدوبى در دٍرُ ّوِ گیزی ٍیزٍس پزداختِ ضذُ ٍ در ثخص دٍم ثزًبهِ19وٍَیذ حوبیت اس ٍ )2019 ّبی پیطٌْبدی ثز اسبس حذالل استبًذاردّبی حوبیت اس وَدوبى در الذاهبت ثطزدٍستبًِ(
وَدوبى در سهبى ضیَو ثیوبری ّبی يفًَی آهذُ است.
more
Persistance des maladies diarrhéiques au Burkina : Dr René Dembélé analyse les causes
YouTube influencer Healthcare Triage talked with WHO's Dr Kate O'Brien about how the COVID-19 vaccine works, how it gets distributed, and how we distribute it equitably.
1:27 Safety questions and concerns about quick development of the vaccine.
7...:18 Have we entered a new age where all vaccines will be developed this easily and quickly?
8:41 Questions about vaccine distribution – how’s it gonna work?
10:36 How do we make sure we distribute the vaccine equitably?
11:59 How do we make sure all countries get the same seat at the vaccine table?
13:29 What are reasonable expectations about the vaccine and life returning to “normal”?
15:14 Misinformation about the vaccine
17:00 Specific myths about the vaccine
18:18 The bigger picture – what have we learned from this pandemic that we should apply in the future?
more
Die neuen Podcast-Folgen werden dienstags gegen 17 Uhr veröffentlicht. Neben Christian Drosten, dem Leiter der Virologie an der Berliner Charité, ist Sandra Ciesek, Direktorin des Instituts für Medizinische Virologie am Universitätsklinikum Fran...kfurt am Main, ein regelmäßiger Gesprächsgast.
Seit Ende Februar 2020 beantwortet Prof. Dr. Christian Drosten (Leiter der Virologie an der Berliner Charité) Fragen zur aktuellen Situation, erklärt Zusammenhänge und schildert, wie er diese Monate persönlich erlebt. Anfang September kam Prof. Dr. Sandra Ciesek (Leiterin der Virologie des Universitätsklinikums Frankfurt) als Gesprächsgast dazu.
more
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...pid Communication is released in advance of updated WHO consolidated guidelines expected later in 2022, to inform national TB programmes and other stakeholders of key changes in the treatment of DR-TB and to allow for rapid transition and planning at the country level.
more
To assess the impact of the COVID-19 pandemic on health and HIV expenditure, UNAIDS carried out a modelling study on fiscal space for health and HIV. From a sample of 28 countries, three countries—the Democratic Republic of the Congo, Jamaica, and Lesotho—were selected to capture health and HIV ...expenditure impacts across countries with especially marked differences in burdens of disease (including HIV prevalence), HIV donor dependency, level of economic development, and geographic location. While the three-country sample is too small to permit findings to be generalized to other countries, these analyses are useful for informing UNAIDS’ work to identify some policy positions to minimize the COVID-19 pandemic’s impact on the HIV response.
more